CLINICAL_TRIALS
trial_result
· 2017-11-24
Clinical Trial Update: Iressa Study in Patients With Salivary Gland Cancer [Phase 2]
Summary
Phase 2 trial of Iressa (gefitinib) in salivary gland cancer has completed enrollment with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Salivary Gland Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-11-24